Agios Pharmaceuticals | AGIO - Capital Ordinaire





Capital Ordinaire Changement Date
AbbVie USD 1.77B 1.75B 2025-06
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amgen USD 541M 1000K 2026-06
Arrowhead Research USD 141.14M 564K 2026-06
Astellas Pharma JPY 1.79B 1.52M 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Bayer EUR 982.42M 0 2026-06
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Daiichi Sankyo JPY 1.82B 30.68M 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 248.88M 4.82M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Merck USD 2.47B 4.93M 2026-03
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 0 2026-06
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
Vertex Pharmaceuticals USD 253.3M 900K 2026-06